ONR’s I2D, TECHx events connect industry innovators with naval S&T priorities
Meeting Announcement
October 6–7 | Abu Dhabi
Dr. Alex Aliper, Co-founder and President of Insilico Medicine, has been invited to speak at the AI Everything Abu Dhabi summit.October 7–9 | Yokohama, Japan
Insilico Medicine will make an appearance at BioJapan 2026, held from October 7 to 9 at PACIFICO Yokohama, at Booth D74.October 7–11 | San Francisco
Dr. Alex Zhavoronkov, Founder and Co-CEO of Insilico Medicine, has been invited to attend the Abundance Longevity Trip, founded by Dr. Peter Diamandis.From October 6 to 8, 2026, the EFX—Expo for Electronics Manufacturing will take place for the first time at the Stuttgart exhibition center. The Fraunhofer Institute for Applied Solid State Physics IAF will be exhibiting at the joint Chip Connect BW area. The focus will be on the institute’s newly launched research activities in the field of AI tools for chip design and chip design for AI applications, as well as its established expertise in III-V semiconductor manufacturing for pilot lines.
UVA Comprehensive Cancer Center will welcome top scientists and physicians working to understand and stop cancer’s metastatic spread for its sixth-annual Michael J. Weber Symposium on Oct. 2.
European policymakers, researchers, healthcare leaders and patient advocates will gather in Stockholm from 14 to 16 October for Momentum 2026. The conference will examine how Europe can shorten the path from cancer research to patient benefit through stronger collaboration and faster adoption of scientific advances. Speakers include Greg Simon, Joanna Drake, Cary Adams and Elisabete Weiderpass. Journalists are welcome to apply for accreditation.
More than 250 leaders and CEOs from healthcare, biotechnology, medicine, venture capital, government and technology gathered in Boston for the 2026 World Medical Innovation Forum, convened by Mass General Brigham in collaboration with Bank of America. This year's forum, which drew more than 2,300 attendees, focused on “Innovation at Scale,” highlighting emerging treatments, artificial intelligence, scientific discovery and new approaches to improving patient care.
As autonomous AI agents evolve from conversational assistants into true scientific collaborators, the pharmaceutical industry is entering the next chapter of its AI transformation, one in which discovery workflows are not merely assisted by AI, but orchestrated by it. To help accelerate the advent of Pharmaceutical Superintelligence, Insilico Medicine (03696.HK), a clinical-stage generative AI-driven drug discovery company, today announced that the Pharma.AI Webinar 2026 Q3 Fall Updates will take place on September 30, from 10 EST. Registration and event details are available at: https://insilico.zoom.us/webinar/register/2417878444165/WN_gLMYTGF2RYW3EoupiucfTA#/registration
The deadline for the United Nations’ Sustainable Development Goals (SDGs) is fast approaching. To address this, the four Schools for Science and Society of the University of Groningen, the Netherlands, will host the Groningen Sustainability Conference from 5 to 10 April 2027 to discuss the future of the SDGs.
The American Academy of Pediatrics hosts its annual National Conference & Exhibition in San Diego for the first time in over a decade, offering the latest information in medical research, education and advocacy for children’s health Oct. 2 – 6, 2026.
Keynote speaker Mikhail “Doctor Mike” Varshavski, D.O. , who creates viral health content for an audience of over 30 million people, joins AAP President Andrew Racine, MD, PhD, FAAP for the conference's opening session on Saturday, Oct. 3. More than 10,700 people are registered to attend